These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10817110)

  • 21. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nefazodone and visual side effects.
    Schwartz K
    Am J Psychiatry; 1997 Jul; 154(7):1038. PubMed ID: 9210763
    [No Abstract]   [Full Text] [Related]  

  • 23. Nefazodone and symptoms suggesting neurotoxicity: a case report.
    Puzantian T; Shaw RJ
    J Clin Psychiatry; 1996 Dec; 57(12):595. PubMed ID: 9010127
    [No Abstract]   [Full Text] [Related]  

  • 24. The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration.
    Khouzam HR
    J Psychosoc Nurs Ment Health Serv; 2000 Aug; 38(8):20-5. PubMed ID: 10959472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic dose range of nefazodone in the treatment of major depression.
    Robinson DS; Marcus RN; Archibald DG; Hardy SA
    J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
    J Clin Psychiatry; 1998 Sep; 59(9):460-4. PubMed ID: 9771816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of open-label nefazodone treatment in patients with panic disorder.
    Papp LA; Coplan JD; Martinez JM; de Jesus M; Gorman JM
    J Clin Psychopharmacol; 2000 Oct; 20(5):544-6. PubMed ID: 11001239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible interaction of zopiclone and nefazodone.
    Alderman CP; Gebauer MG; Gilbert AL; Condon JT
    Ann Pharmacother; 2001 Nov; 35(11):1378-80. PubMed ID: 11724087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nefazodone for mood disorder associated with epilepsy.
    Balon R
    J Clin Psychiatry; 1998 Dec; 59(12):690. PubMed ID: 9921708
    [No Abstract]   [Full Text] [Related]  

  • 30. A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
    Mischoulon D; Opitz G; Kelly K; Fava M; Rosenbaum JF
    Depress Anxiety; 2004; 19(1):43-50. PubMed ID: 14978785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nefazodone withdrawal symptoms.
    Benazzi F
    Can J Psychiatry; 1998 Mar; 43(2):194-5. PubMed ID: 9533975
    [No Abstract]   [Full Text] [Related]  

  • 32. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
    Feiger AD; Bielski RJ; Bremner J; Heiser JF; Trivedi M; Wilcox CS; Roberts DL; Kensler TT; McQuade RD; Kaplita SB; Archibald DG
    Int Clin Psychopharmacol; 1999 Jan; 14(1):19-28. PubMed ID: 10221638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The antidepressant nefazodone. Healthy sleep fosters compliance].
    Volz HP
    MMW Fortschr Med; 2001 May; 143 Suppl 2():97. PubMed ID: 11434278
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of posttraumatic stress disorder with nefazodone.
    Davidson JR; Weisler RH; Malik ML; Connor KM
    Int Clin Psychopharmacol; 1998 May; 13(3):111-3. PubMed ID: 9690977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remission of cancer chemotherapy-induced emesis during antidepressant therapy with nefazodone.
    Khouzam HR; Monteiro AJ; Gerken ME
    Psychosom Med; 1998; 60(1):89-91. PubMed ID: 9492245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible nefazodone-induced liver failure.
    Eloubeidi MA; Gaede JT; Swaim MW
    Dig Dis Sci; 2000 May; 45(5):1036-8. PubMed ID: 10795773
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
    Castañeda R; Levy R; Westreich LM; Sussman N
    J Clin Psychiatry; 1996 Oct; 57(10):485-6. PubMed ID: 8909335
    [No Abstract]   [Full Text] [Related]  

  • 40. Reassessment of nefazodone.
    Bryant SG
    Am J Health Syst Pharm; 1996 Oct; 53(19):2339-40, 2343. PubMed ID: 8893078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.